To recognize that continuity of care is a vital requirement in the appropriate use of medications; further, to strongly encourage pharmacists to assume professional responsibility for ensuring the continuity of pharmaceutical care as patients move from one setting to another (e.g., ambulatory care to inpatient care to home care); further, to encourage the development of strategies to address the gaps in continuity of pharmaceutical care.
lished a Continuity of Care Task Force in response to the approval of the continuity of care policy statement. Members included representatives from each of the ASHP sections, forums, and practice groups, representing home care, community, inpatient, long-term-care, clinical, and ambulatory care practitioners and pharmacy management. The Task Force was charged with developing a paper that defined CCMM, identified practice gaps and barriers that contribute to the discontinuity of care, outlined a common data set, provided examples of current practices that demonstrate CCMM, and recommended actions for improving or implementing CCMM.
Current state of affairs
The health care arena is multifaceted and complex. Patients often receive care from a myriad of providers, in various locations, and across many levels of the continuum of care. [2] [3] [4] Despite the efforts to emphasize primary provider-driven oversight of all aspects of care, the current health infrastructure does not include "cooperative systems," which support and facilitate effective communication and coordination. 5 For this reason, health care professionals find it difficult to respond to the discontinuities and fragmentation in patients' care. 6 The inherent complexities of the health care environment create gaps in the CCMM and have the potential to cause failures. 7 Health care professionals, including pharmacists, must address these gaps to provide high-quality patient care.
Medications play a key role in the success or failure of care. 7, 8 Preventable drug-related morbidity is the cause of many hospital admissions, yet the continuous management of medication therapy remains elusive. 5 Deficiencies in the sharing of patient information are core contributing factors to the discontinuity of care, which is a logical precursor to medical errors. 6, 9 Although pharmacists are the medication management experts, they must use a multidisciplinary approach to allow the continuous management of patients' medication regimens. 10 Physicians, pharmacists, nurses, and other allied health professionals can bridge these medication management gaps and optimize patient outcomes by working together.
agreed, then revision of the definition was required. When revisions were required, anonymous verbatim comments were provided to the author of the component in question. After revisions were complete, the voting procedure was repeated, and the process continued until consensus was reached. This process was also used to build the common data set for medication management, which appears in the appendix. The Task Force employed a more simplified group review and consensus process for the identified practice gaps and barriers and the recommendations for enhancing or implementing CCMM.
Defining continuity of care and CCMM
Continuity of care. The term
Building consensus
The Task Force met regularly by conference call between February and December 2004. Sections of this paper, including the definition of CCMM, were developed through an evidencebased, consensus-building approach using a modified Delphi process. 11 This validated, iterative process required that each Task Force member rate the definition of the particular component of the paper with one of the following descriptors: strongly agree, agree, disagree, or strongly disagree. [12] [13] [14] The use of substitute participants was not permitted. Each member was required to vote, and no member was allowed to abstain. Evidence was required to support dissenting opinions. All responses were submitted to ASHP staff. If any Task Force member strongly discontinuity of care has been used in the pharmacy literature for decades with no formal definition, yet the term's predominant meaning is "a relationship between present and past care requiring a flow of information and a care plan." 10, 15 Because continuity of care has been defined differently by various health care professionals, the Task Force defined the term in relation to medication management, which is more applicable to pharmacists.
A report commissioned by the Canadian Institute for Health Information and the Conference of Canadian Health Ministers defined continuity of care as having three components (informational, relational, and management continuity) that shape patients' perception of their health care experience and how that care is provided over time. 16 Canadian pharmacists' focus on the importance of continuity of care led to the publication of a compilation of resources and case examples of efforts to promote and achieve positive patient outcomes. 5 Continuity of care guidelines developed in Australia focus on medication management and consist of seven principles: (1) identifying a person to coordinate the medication discharge plan, (2) obtaining an accurate medication history, (3) evaluating the complete medication list for appropriateness, (4) developing a treatment plan that is part of the overall care plan, (5) dispensing an adequate amount of medication at discharge, (6) ensuring the patient has been educated about the discharge treatment plan, and (7) communicating to follow-up health care providers the patient's admission, medication changes, and discharge plans. 17 Resources and programs in Australia have been developed and implemented to assist with achieving these principles in all practice settings.
In the United States, the Joint Commission on Accreditation of Healthcare Organizations (JCAHO)
Continuity of Care in Medication Management Definition
(as defined by the ASHP Continuity of Care Task Force)
a. Continuity of care is a longitudinal process that is coordinated and provided among practitioners and organizations over time, consistent with the ongoing needs of the individual patient. b. Medication management is an essential component of continuity of care. c. All entities responsible for an individual's health care, including practitioners from multiple professions, health care organizations, and the individuals themselves, should strive for cohesive care across a continuum of sites (from intensive care to self-care) that is responsive to changes in needs over time.
Aspects and characteristics of the care process that are necessary for continuity include ASHP policy on continuity of care encourages pharmacists to assume the professional responsibility for ensuring continuity of care in medication management.
introduced a new patient safety goal in 2005, requiring health care organizations to "accurately and completely reconcile medications across the continuum of care." 18 In addition, the Centers for Medicare and Medicaid Services established the Chronic Care Improvement Program, authorized by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, to study the impact of better continuity of care management of up to 300,000 Medicare recipients. 19 In 1998, the Canadian Society of Hospital Pharmacists and the Canadian Pharmacists Association defined seamless care as the desirable continuity of care delivered to a patient in the health care system across the spectrum of caregivers and their environments. Pharmacy care is carried out without interruption such that when one pharmacist ceases to be responsible for the patient's care, another pharmacist or health care professional accepts responsibility for the patient's care. 20 In 2003, the American Academy of Family Physicians defined continuity of care as "the process by which the patient and the physician are cooperatively involved in ongoing health care management toward the goal of high quality, cost-effective medical care." 21 However, the Task Force believes that continuity of care and CCMM require a multidisciplinary approach.
Freeman and colleagues 22 identified more than 10 distinct definitions of continuity of care. The three most common were (1) longitudinal or provider continuity (seeing the same professional), (2) continuity across the secondary and primary care interface (follow up on patient after he or she is transferred from a specialist to a generalist's service), and (3) continuity of information through medical records. They also identified continuity of care as a multifaceted concept that includes continuity across organizational boundaries, continuity of personnel, continuity of information, and continuity over time. Based on these findings, six central elements of continuity of care were proposed: (1) the experience of a coordinated and smooth progression of care from the patients' point of view (experienced continuity), (2) complete information transfer following the patient (continuity of information), (3) effective communication between professionals and services providing care to patients (cross-boundary and team continuity), (4) flexibility and the ability to adjust to the needs of the individual over time (flexible continuity), (5) care from as few professionals as possible, consistent with other needs (longitudinal continuity), and (6) provision of the name of at least one health care provider with whom the patient can establish and maintain a professional relationship (relational or personal continuity).
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CCMM. The definition of CCMM developed by the Task Force (see box) is consistent with other published work in this arena and delineates the core elements required to provide effective CCMM and necessary for its integration with the total care of the patient.
This definition of CCMM provides a framework for analyzing the different areas of practice that are prone to failures in medication management (practice gaps) and guidelines for identifying the barriers to its achievement.
Identifying practice gaps and analyzing barriers
Practice gaps are breaks in the provision of continuous patient care. These gaps are caused by barriers to the delivery of care, one of which is patients' transition among different levels of care. Health care delivery must be continuous and integrated to be of high quality and protect the patient from harm. The Task Force identified eight main categories of practice gaps in continuity of care: 
ASHP REPORTS Continuity of care
Materials has advanced information exchange by developing an international standard to be used by information technology system vendors when creating a uniform standard electronic medical record. 24 The Task Force realized that another major step in achieving informational continuity was to establish a common data set of patient information to enhance the timely communication of pertinent information and standardize information management in patient care among health care providers.
A common data set attempts to identify characteristics that differentiate patients from each other. These attributes may significantly influence the provision and allocation of resources for each patient's care and can serve to identify traits that must be accounted for in order to provide safe care. 25 A common data set also empowers patients, as well as their caregivers, allowing them to be informed and knowledgeable when questions are asked of them. Patients are able to access and assist in updating their information, with each point in a data set serving as a trigger for the validation, rather than provision, of information from memory. This is especially important in limiting frustration in patients who are ill or otherwise seeking medical care.
A common data set for patients also benefits the health care system by facilitating the initiation of care in a timely fashion. 18, 19 Patient validation of the data set expedites assessment and initiation of treatment, diminishes the duplication of effort with each encounter, and fosters consistency. The data set should be used early and frequently to promote seamless patient entry and transition through the system. It also enhances compliance with the JCAHO requirements for medication reconciliation. Some sectors of health care are required to maintain current and complete medication profiles for regulatory and licensure compliance 8 . Technology gaps, which are attributable to availability, level of computer knowledge, training, limitations, variability, contingency plans, change, barcoding, physician order entry, and Internet.
In addition to identifying practice gaps, the Task Force discussed informational, relationship, and management barriers to the medication-use process. 16 Informational barriers may include obstacles in communication, coordination of care, and clinical practice, which can affect all aspects of the medication selection and delivery process, the provision of information to the patient, and proper documentation in the medical record. Relationship barriers involve issues surrounding the patient, caregivers, and health professionals. Special consideration needs to be given to the patient's psychosocial status, as well as the obstacles presented to providers. Strong relationships between the patient and provider have been demonstrated to improve patient safety and quality of care. 23 Management barriers are related to organizations, policies, and technology. Organizational and governmental policies or regulations may increase the rigidity within an institution; new processes and technologies for improving the medication-use process may require employees to receive additional education and skills and cause new practice gaps.
Building a common data set
Technology and computerization allow for the quick and easy dissemination of information. This is especially important in today's health care environment, where advances in the diagnosis and treatment of various illnesses occur at a rapid pace. Information exchange is one of the largest components of CCMM. Concise, consistent, and easily transferable data ensure the quality and safety of medication management. The American Society for Testing and (i.e., long-term-care facilities, home health agencies, and hospital discharge planning departments). The full implementation in 2006 of the JCAHO interprovider and intraprovider National Patient Safety Goal for medication reconciliation at each patient transfer should highlight and initiate the development of systems and tools to facilitate the process.
There are some obstacles to creating and maintaining a common data set. Data may be documented and tracked through various computerized information systems that may not be standardized and integrated across practice settings. Variables of a common data set require perpetual revision. More importantly, outdated information jeopardizes the internal validity of the data set and undermines its intent. Therefore, it is still the responsibility of the health care provider to confirm the accuracy of each portion of the data set as it pertains to the condition of the patient.
In addition, each health care provider will continue to manage an aggregated data set (i.e., the medical record) for each patient. Inclusion of dates of service and dates of revision of the data set is also recommended. Ideally, one person ultimately coordinates the patient's care. 17 The consensusdeveloped common data set, found in the appendix, will enhance these coordination efforts by encouraging standardization of relevant information that will support timely decisions about the patient's care.
Examples of CCMM programs
The Task Force solicited examples of initiatives to improve CCMM through ASHP list servers, networking, and interviews. Pharmacists whose organizations are currently pursuing CCMM programs shared some of their experiences and insight regarding processes, barriers, and recommendations from their respective organizations. These examples further support the emphasis and efforts in the recommendations outlined by the Task Force later in this paper. Kaiser Permanente, Kensington, Maryland. Kaiser Permanente is mainly a closed health maintenance organization with employee physicians and pharmacists using organization-owned hospitals. In Maryland, Kaiser contracts beds with local hospitals and places Kaiser pharmacists and other health care providers within hospitals. All patient medical information is accessible through a computer or telephone anywhere in the country. Kaiser has developed guidelines for all types of care, and heath care providers within the system are expected to follow them. Every member of the health care team plays a vital role in information gathering and maintaining the continuity of care.
University of Iowa Hospitals and
When working with a non-Kaiser hospital, multiple barriers to CCMM were encountered by Kaiser. First, Kaiser pharmacists were not automatically accepted by the hospital pharmacists or other health professionals, but over time a relationship developed that eased the transfer of medication data for the patient. Second, Kaiser patients are often the sickest patients in the hospital with shorter lengths of stay, which made medical care more challenging. Third, Kaiser had to comply with individual formularies when their patients were treated at a specific institution, but were switched to drugs on Kaiser's formulary at discharge. Fourth, the demand for more Kaiser pharmacists on rounds grew once the value of their services was realized, which reduced their ability to extend medication management services to more patients. Finally, much like the findings of UIHC, when Kaiser patients are transferred or discharged, a computer interface with hospitals, community pharmacies, and longPatients entered COC1 either before admission to the hospital via the community pharmacist or upon admission via the hospital pharmacist. Upon admission, patients were asked what pharmacies they frequented and if the pharmacy was under contract with COC1. All patients gave written consent to participate in the program. Upon the patient's admission, the COC1 pharmacy faxed the pharmacy records to the hospital. The hospital pharmacist then completed a patient history, which included medical, social, and family histories. This information was entered into a comprehensive database (developed by the hospital's information technology department) that was accessible from any computer in the facility. At discharge, the patient's information, including his or her medication list, was faxed from the database to the pharmacy.
UIHC encountered multiple problems with the program. First, the community pharmacies' computer systems were not interfaced with UIHC's system. Second, it was unclear how many years of patient information should be faxed. Third, there was a lack of physician involvement. Many times the community pharmacist did not know the patient well enough to assist the hospital pharmacist in understanding the patient's issues or reasons for certain medications. Fourth, a considerable amount of time was required to educate patients and pharmacists about the program and to record each patient's medical history. In addition, it was difficult to address every new admission or discharge since pharmacy did not have a presence on every unit every day of the week. Finally, UIHC did not contract with nursing homes, which led to incomplete transfer of patient information.
Solutions to these problems include focusing on one disease state or one nursing unit before expanding the service to other areas, which would allow the educational process to term-care facilities is required to facilitate the transfer of patient information. This is especially important because if a patient goes to a physician, pharmacy, or hospital outside of the Kaiser system, the patient's information would be lost.
When implementing a CCMM program, Kaiser recommends using pharmacists who are experienced in the acute care setting and possess excellent clinical skills. These pharmacists should participate in the hospital's activities, both professional and social, in order to nurture relationships with other health professionals. The pharmacists should also provide a complete service with quick turnaround and anticipate patients' and providers' needs in order to prevent delays in the transition from hospital to home or alternative site. Keeping abreast of the latest guidelines in treatment as well as cost-effectiveness data solidifies the pharmacist's role on the multidisciplinary team. 
Call to action
The Task Force encourages ASHP to continue to invest in efforts that improve patient care by initiating collaboration with others with an aim to increase the focus on CCMM by developing standards, resources, technology, and methods for implementing care models.
Conclusion
Pharmacists, physicians, nurses, health administrators, educators, and professional groups are integral in the provision of CCMM. Further discussion should occur among health care providers and leaders to encourage the adoption and implementation of CCMM programs.
